- Report
- January 2022
- 200 Pages
Global
From €6826EUR$7,500USD£5,852GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1138EUR$1,250USD£975GBP
- Report
- January 2022
- 60 Pages
Global
From €3595EUR$3,950USD£3,082GBP
- Report
- April 2023
- 111 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- August 2024
- 77 Pages
Global
From €3500EUR$4,120USD£3,106GBP
Complex Regional Pain Syndrome (CRPS) is a chronic pain disorder that affects the peripheral and central nervous systems. It is characterized by severe, burning pain, swelling, and changes in skin color and temperature. Treatment for CRPS typically involves a combination of medications, physical therapy, and psychological therapy.
Drugs used to treat CRPS include non-steroidal anti-inflammatory drugs (NSAIDs), opioids, anticonvulsants, antidepressants, and topical anesthetics. These drugs are used to reduce pain, inflammation, and muscle spasms. In some cases, nerve blocks and injections may be used to provide relief.
The CRPS drug market is a subset of the larger Central Nervous System (CNS) drug market. CNS drugs are used to treat a variety of neurological disorders, including Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and epilepsy.
Some companies in the CRPS drug market include Pfizer, Novartis, GlaxoSmithKline, Merck, and Johnson & Johnson. Show Less Read more